Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan
· Delayed Price · Currency is JPY 2,038.00
-30.00 (-1.45%)
Jun 13, 2025, 3:30 PM JST
Zeria Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 12,618 | 9,508 | 7,272 | 5,721 | 3,922 | Upgrade
|
| Depreciation & Amortization | 7,554 | 7,555 | 6,148 | 5,399 | 4,435 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 32 | Upgrade
|
| Loss (Gain) From Sale of Investments | 208 | -499 | -19 | -14 | -375 | Upgrade
|
| Loss (Gain) on Equity Investments | 276 | - | - | - | - | Upgrade
|
| Other Operating Activities | -1,039 | -906 | -530 | -864 | -512 | Upgrade
|
| Change in Accounts Receivable | -4,800 | -2,075 | -171 | -2,029 | 825 | Upgrade
|
| Change in Inventory | -1,647 | -863 | -150 | -542 | -753 | Upgrade
|
| Change in Accounts Payable | 567 | 1,052 | -207 | 284 | -40 | Upgrade
|
| Change in Other Net Operating Assets | -815 | -1,589 | 814 | 995 | -640 | Upgrade
|
| Operating Cash Flow | 12,922 | 12,183 | 13,157 | 8,950 | 6,894 | Upgrade
|
| Operating Cash Flow Growth | 6.07% | -7.40% | 47.01% | 29.82% | -4.92% | Upgrade
|
| Capital Expenditures | -1,429 | -2,900 | -2,400 | -1,064 | -734 | Upgrade
|
| Cash Acquisitions | - | -623 | - | - | -2,464 | Upgrade
|
| Sale (Purchase) of Intangibles | -1,304 | -998 | -257 | -356 | -15,398 | Upgrade
|
| Investment in Securities | 1,662 | 473 | 58 | -1,477 | 1,173 | Upgrade
|
| Other Investing Activities | 21 | 96 | 25 | 5 | -37 | Upgrade
|
| Investing Cash Flow | -1,050 | -3,952 | -2,574 | -2,892 | -17,460 | Upgrade
|
| Short-Term Debt Issued | - | - | 279 | - | 12,744 | Upgrade
|
| Long-Term Debt Issued | 3,273 | 500 | 500 | 16,158 | 4,500 | Upgrade
|
| Total Debt Issued | 3,273 | 500 | 779 | 16,158 | 17,244 | Upgrade
|
| Short-Term Debt Repaid | -143 | -560 | - | -13,241 | - | Upgrade
|
| Long-Term Debt Repaid | -8,515 | -5,778 | -5,628 | -3,388 | -3,122 | Upgrade
|
| Total Debt Repaid | -8,658 | -6,338 | -5,628 | -16,629 | -3,122 | Upgrade
|
| Net Debt Issued (Repaid) | -5,385 | -5,838 | -4,849 | -471 | 14,122 | Upgrade
|
| Repurchase of Common Stock | - | - | -673 | -2,603 | -1,154 | Upgrade
|
| Dividends Paid | -1,976 | -1,935 | -1,590 | -1,538 | -1,568 | Upgrade
|
| Other Financing Activities | -395 | -351 | -303 | -229 | -215 | Upgrade
|
| Financing Cash Flow | -7,756 | -8,124 | -7,415 | -4,841 | 11,185 | Upgrade
|
| Foreign Exchange Rate Adjustments | 749 | 2,402 | 1,346 | 564 | 169 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -2 | 1 | - | 128 | - | Upgrade
|
| Net Cash Flow | 4,863 | 2,510 | 4,514 | 1,909 | 788 | Upgrade
|
| Free Cash Flow | 11,493 | 9,283 | 10,757 | 7,886 | 6,160 | Upgrade
|
| Free Cash Flow Growth | 23.81% | -13.70% | 36.41% | 28.02% | -7.07% | Upgrade
|
| Free Cash Flow Margin | 13.16% | 12.26% | 15.73% | 13.25% | 11.11% | Upgrade
|
| Free Cash Flow Per Share | 260.73 | 210.59 | 243.52 | 174.71 | 133.70 | Upgrade
|
| Cash Interest Paid | 492 | 446 | 300 | 304 | 223 | Upgrade
|
| Cash Income Tax Paid | 1,001 | 915 | 564 | 874 | 526 | Upgrade
|
| Levered Free Cash Flow | 7,627 | 7,850 | 8,807 | 6,071 | -12,962 | Upgrade
|
| Unlevered Free Cash Flow | 7,910 | 8,136 | 9,017 | 6,268 | -12,813 | Upgrade
|
| Change in Net Working Capital | 4,535 | 1,535 | 108 | 1,690 | 3,268 | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.